Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.65B
sum of reported positions
Reported positions
543
Changes vs prior quarter
567
60 new · 52 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 344 measured positions in 8 quarters, the typical new or larger position finished −1.0 pts against the S&P 500 and 48% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 592K | $72.4M | 1.3% | |
| 109K | $62.8M | 1.1% | |
| 652K | $62.7M | 1.1% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $4.72B | $5.65B |
| Positions | 535 | 543 |
| Biggest line | — | Mercury Systems 1% |
| 848K |
| $62.4M |
| 1.1% |
| 565K | $55M | 1.0% |
| 690K | $48M | 0.8% |
| 659K | $47.7M | 0.8% |
| 1.58M | $47.2M | 0.8% |
| 611K | $46.4M | 0.8% |
| 1.63M | $45.7M | 0.8% |
| 149K | $44.2M | 0.8% |
| 545K | $42.7M | 0.8% |
| 112K | $42.4M | 0.7% |
| 426K | $41.5M | 0.7% |
| 172K | $40.1M | 0.7% |
| 357K | $40.1M | 0.7% |
| 234K | $37.6M | 0.7% |
| 540K | $37.6M | 0.7% |
| 227K | $37.3M | 0.7% |
| 601K | $36.8M | 0.7% |
| 230K | $35.7M | 0.6% |
| 345K | $34.4M | 0.6% |
| 660K | $34.4M | 0.6% |
| 670K | $34.3M | 0.6% |
| 479K | $33.4M | 0.6% |
Oil States International (OIS)
1.08M → 1.29M shares (+20%)
Ncino (NCNO)
514K → 632K shares (+23%)
Oruka Therapeutics (ORKA)
126K → 107K shares (−15%)
Generac (GNRC)
50K → 35K shares (−30%)
Array Technologies (ARRY)
1.35M shares
Simulations Plus (SLP)
389K → 539K shares (+39%)
APi Group (APG)
197K → 232K shares (+18%)
Monte Rosa Therapeutics (GLUE)
32K → 406K shares (+1168%)
Barrett Business Services (BBSI)
182K → 274K shares (+51%)
Tectonic Therapeutic (TECX)
287K → 282K shares (−2%)
U.S. Physical Therapy, Inc. (USPH)
68K → 141K shares (+108%)
Acuity Brands (AYI)
26K → 26K shares (−3%)
Horizon Bancorp Inc (HBNC)
493K → 481K shares (−2%)
Merck (MRK)
79K → 75K shares (−5%)
Tfi International (TFII)
78K → 67K shares (−14%)
Xeris Biopharma Holdings (XERS)
1.24M → 1.21M shares (−3%)
Aviat Networks (AVNW)
438K → 430K shares (−2%)
Stanley Black & Decker (SWK)
116K → 101K shares (−13%)
Atlas Energy Solutions, Inc. (AESI)
820K → 571K shares (−30%)
Lakeland Financial (LKFN)
157K → 152K shares (−3%)
Capital Bancorp (CBNK)
269K → 264K shares (−2%)
Abercrombie & Fitch (ANF)
150K → 103K shares (−32%)
Hecla Mining (HL)
449K → 597K shares (+33%)
Surgery Partners (SGRY)
157K → 548K shares (+250%)
California Bancorp (BCAL)
431K → 442K shares (+3%)